Deadline: 30-Jan-2025 Pfizer is pleased to announce the Health Services Research Grant to Improve Management of mBC Patients Treated with Tucatinib. The intent of this RFP is to support Investigator Sponsored/General Research projects that will implement and assess the impact of therapy management approaches for patients with HER2+ Metastatic Breast Cancer (mBC) receiving tucatinib in… [Read More]
The post Pfizer Health Services Research Grant 2025 first appeared on fundsforNGOs.
Source: www2.fundsforngos.org…
